The invention is directed to compounds and methods of synthesizing hydroxyethlamino amides and their use in treatment of aspartyl protease mediated diseases and conditions.

 
Web www.patentalert.com

< Macrocyclic beta-secretase inhibitors for the treatment of Alzheimer's disease

> HMG-CoA reductase inhibitors and method
~ 00453